Kardigan
South San Francisco
About Kardigan
Kardigan is a biopharmaceutical company developing a pipeline of personalized medicines to treat and potentially cure cardiovascular diseases. The company utilizes a proprietary Cardiac Intelligence R&D platform to confirm markers for safety, efficacy, and patient selection before human trials. Kardigan integrates AI-based tools into its clinical trials to optimize study design and increase confidence in results.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $554.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Oct 2025)
- Website: kardigan.bio
Industries & Categories
Artificial Intelligence (AI), Biopharma, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/kardigan-118540 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.